Ontario Brain Institute
The Ontario Brain Institute, established in 2010 and based in Toronto, is a provincially-funded, not-for-profit research center dedicated to advancing neuroscience. Its mission is to position Ontario as a global leader in brain research, commercialization, and care. The Institute fosters collaborations among researchers, clinicians, industry stakeholders, patients, and their advocates to drive innovation and develop products and services aimed at improving the lives of individuals affected by brain disorders. By providing grants and financing to companies in the neurotechnology sector across Canada, the Ontario Brain Institute seeks to maximize the impact of neuroscience and enhance the overall landscape of brain health and treatment.
Cerebtalk specializes in brain-computer interface (BCI) technology aimed at enhancing communication for individuals with severe motor impairments, such as those affected by amyotrophic lateral sclerosis, spinal cord injuries, strokes, cerebral palsy, and non-verbal autism. In addition to its communication tools, the company develops wireless in-ear EEG earphones that work in conjunction with a dedicated application. This technology allows users to monitor their stress levels, sleep quality, and physical activity, thereby promoting overall physical and mental wellness. Cerebtalk's innovative approach addresses both communication barriers and wellness tracking for users with diverse needs.
Zentrela
Seed Round in 2019
Zentrela Inc. is a neurotechnology company based in Hamilton, Canada, that specializes in developing end-to-end EEG systems aimed at reducing accidents caused by cognitive impairment during driving or working. Founded in 2015, Zentrela has created the Zentrela wellness system, a wearable device that leverages artificial intelligence to decode human brain activity. The company focuses on the legalized cannabis industry, utilizing its proprietary technology to create a comprehensive scientific database that captures consumer experiences with cannabis products. By analyzing brainwave data, Zentrela aims to transform the development, promotion, and sale of cannabis products, shifting the industry's focus from plant-based data to consumer experience insights. Its technology also includes applications for workplace safety, enabling professional drivers to maintain alertness and better manage cognitive challenges associated with THC use.
HiNT (Healthcare Innovation in NeuroTechnology)
Grant in 2017
HiNT is developing a wearable point-of-care monitoring device that detects a stroke with EEG and alerts high-risk patients, Its care givers, and their medical support team when the patient is having a stroke.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.